Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
View Patent ↗The present invention provides methods for preventing colon cancer by administering, to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to prevent colon cancer, which composition inhibits COX-2. The present invention also provides methods for treating inflammation locally in the intestines comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to treat inflammation. In one embodiment, the polymeric proanthocyanidin compound is crofelemer. The present invention in alternative embodiments provides methods for treating pain locally in the intestines and treating inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, as well as for treating familial adenomatous polyposis (FAP).
1. A method of treating pain associated with inflammatory bowel disease comprising administering an extract from a Croton species or Calophyllum species to a subject in need thereof, wherein the dosage of the extract is bioequivalent to 250 mg to 500 mg of crofelemer per day and the inflammatory bowel disease is Crohn's disease or ulcerative colitis.
2. The method of claim 1 , wherein the subject experiences an increase in the number of pain-free days.
3. The method of claim 1 , wherein the dosage is 250 mg to 500 mg of crofelemer per day.
4. The method of claim 3 , wherein the subject experiences an increase in the number of pain-free days.
5. The method of claim 1 , wherein the dosage is administered twice per day.
6. The method of claim 1 , wherein the extract is in a tablet form and the tablet has an enteric coating.
7. The method of claim 1 , wherein the extract is in a granular or powder form and particles of the granular or powder form have an enteric coating.
8. A method of treating inflammation associated with inflammatory bowel disease comprising administering an extract from a Croton species or Calophyllum species to a subject in need thereof, wherein the dosage of the extract is bioequivalent to 250 mg to 500 mg of crofelemer per day and the inflammatory bowel disease is Crohn's disease or ulcerative colitis.
9. The method of claim 8 , wherein the level of inflammation in the subject is decreased by at least 20%.
10. The method of claim 8 , wherein the dosage is 250 mg to 500 mg of crofelemer per day.
11. The method of claim 10 , wherein the level of inflammation in the subject is decreased by at least 20%.
12. The method of claim 8 , wherein the dosage is administered twice per day.
13. The method of claim 8 , wherein the extract is in a tablet form and the tablet has an enteric coating.
14. The method of claim 8 , wherein the extract is in a granular or powder form and particles of the granular or powder form have an enteric coating.